Literature DB >> 27522255

Patchouli alcohol attenuates experimental atherosclerosis via inhibiting macrophage infiltration and its inflammatory responses.

Hua-Ting Wang1, Zun-Zhe Wang2, Zai-Cun Wang3, Shu-Mei Wang2, Xiao-Jun Cai2, Guo-Hai Su2, Zu-Yi Yuan4.   

Abstract

Patchouli alcohol (PA) is a tricyclic sesquiterpene extracted from a traditional Chinese herb pogostemonis herba. Literatures have proven that PA could inhibit inflammatory responses in various inflammatory disease models. However, whether PA could protect against atherosclerosis, a chronic vascular inflammation, is unknown. In this study, we sought to explore this issue in atherosclerosis-prone apolipoprotein E knockout mice fed an atherogenic diet, with or without daily PA intragastrical administration (40mg/kg). Our results showed that PA administration did not change plasma lipids metabolism, however, it significantly attenuated atherosclerotic plaque burdens in both the aorta and the aortic root. The lesional macrophage content, shown as Mac2 positive areas, was reduced, while the lesional smooth muscle cell and collagen content, shown as α-SMA positive areas and by Sirius red staining, respectively, was not affected in PA-treated mice, compared with non-treated controls. Aortic mRNA expression of macrophage inflammatory cytokines, including MCP-1, iNOS, IL-1β, IL-6, CXCL9 and CXCL11, was also reduced in PA-treated mice. Therefore, we demonstrated that PA could attenuate atherosclerosis, possibly by inhibiting macrophage infiltration and its inflammatory responses.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Macrophage infiltration; Macrophage inflammatory responses; Patchouli alcohol; Pogostemonis herba

Mesh:

Substances:

Year:  2016        PMID: 27522255     DOI: 10.1016/j.biopha.2016.08.005

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice.

Authors:  Qiu-Ying Yan; Jian-Lu Lv; Xing-Yi Shen; Xing-Nan Ou-Yang; Juan-Zhen Yang; Rui-Fang Nie; Jian Lu; Yu-Jie Huang; Jia-Ying Wang; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2022-01-28       Impact factor: 7.169

2.  Tongnao Decoction (TND) Alleviated Atherosclerosis by Playing Lowering Lipid, Anti-Inflammatory, and Antioxidant Roles.

Authors:  Hui Jiang; Jianli Wang; Li Sheng; Xiaoyu Xu; Bingmei Zhou; Luying Shen; Minghua Wu
Journal:  Oxid Med Cell Longev       Date:  2022-05-25       Impact factor: 7.310

Review 3.  Availability, Pharmaceutics, Security, Pharmacokinetics, and Pharmacological Activities of Patchouli Alcohol.

Authors:  Guanying Hu; Cheng Peng; Xiaofang Xie; Sanyin Zhang; Xiaoyu Cao
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-21       Impact factor: 2.629

4.  Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway.

Authors:  Dafeng Yang; Shenglan Tan; Zhousheng Yang; Pei Jiang; Caie Qin; Qiong Yuan; Ruili Dang; Xiaoxia Yao; Jian Qu; Qiong Lu; Ping Xu; Bikui Zhang; Daxiong Xiang; Lei Chen
Journal:  Biomed Res Int       Date:  2018-02-28       Impact factor: 3.411

Review 5.  Efficacy of Terpenoid in Attenuating Aortic Atherosclerosis in Apolipoprotein-E Deficient Mice: A Meta-Analysis of Animal Studies.

Authors:  Han Liu; Yang Zhang; Siqiao Sun; Shuai Wang
Journal:  Biomed Res Int       Date:  2019-07-17       Impact factor: 3.411

Review 6.  Potential benefits of patchouli alcohol in prevention of human diseases: A mechanistic review.

Authors:  Hee-Seop Lee; Jihye Lee; Dmitriy Smolensky; Seong-Ho Lee
Journal:  Int Immunopharmacol       Date:  2020-10-08       Impact factor: 4.932

Review 7.  Pharmacological activities and mechanisms of action of Pogostemon cablin Benth: a review.

Authors:  Chen Junren; Xie Xiaofang; Li Mengting; Xiong Qiuyun; Li Gangmin; Zhang Huiqiong; Chen Guanru; Xu Xin; Yin Yanpeng; Peng Fu; Peng Cheng
Journal:  Chin Med       Date:  2021-01-07       Impact factor: 5.455

8.  The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.

Authors:  Yuyan Dong; Juxiang Liu; Jing Ma; Jinxing Quan; Yanxia Bao; Yaqiang Cui
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.